GSK plc

GSK plc, formerly known as GlaxoSmithKline plc, is an international healthcare company that engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products. The company is headquartered in Brentford, the United Kingdom and was founded in 1715. GSK plc operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare.

The Pharmaceuticals segment offers medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. The Vaccines segment manufactures and markets pediatric and adult vaccines, as well as travel vaccines. The Consumer Healthcare segment offers products in wellness, oral health, nutrition, and skin health categories. Its products include nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews.

GSK plc has established collaboration agreements with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. It also has strategic partnerships with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company has more than 100,000 employees in over 150 countries worldwide and reported revenues of £30.3 billion in 2020. GSK plc is committed to developing innovative medicines and vaccines for the prevention and treatment of diseases, and to providing consumers with a broad range of healthcare products.